Our contract research organization (CRO) provides specialty bioanalytical testing to the biotechnology and pharmaceutical industry for small molecule LC-MS/MS analysis (active drug, metabolites, and co-administrative drugs) in tissues and biological fluids. The bioanalytical services we offer support drug development programs from preclinical to late-stage clinical trials. As bioanalytical experts, we understand the balance between quality scientific data, rapid turnaround times, and cost-effectiveness.
Origin strives to deliver accurate and reliable data within client timelines in a cost-effective manner. By forming strong collaborations with our Sponsors to ensure excellent customer service, Sponsors are able to advance their drug development programs and ultimately contribute to the health and safety of patients around the globe.